Litigation Details for Taiho Pharmaceutical Co., Ltd. v. Eugia Pharma Specialities Ltd. (D. Del. 2019)
✉ Email this page to a colleague
Taiho Pharmaceutical Co., Ltd. v. Eugia Pharma Specialities Ltd. (D. Del. 2019)
| Docket | 1:19-cv-02309-CFC | Date Filed | 2019-12-19 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | |
| Patents | 10,456,399; 10,457,666; 7,799,783; 9,527,833; RE46,284 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Taiho Pharmaceutical Co., Ltd. v. Eugia Pharma Specialities Ltd.
The small molecule drug covered by the patents cited in this case is ⤷ Start Trial .
Details for Taiho Pharmaceutical Co., Ltd. v. Eugia Pharma Specialities Ltd. (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-12-19 | 139 | Opinion - Memorandum Opinion | 10,456,399 (the #399 patent). Tr. 473:18-22. He further testified that "you can't apportion…The #284 patent is a reissue of U.S. Patent No. 7,799,783 (the #783 Patent). The #783 patent was filed… #284 patent and U.S. Patent Nos. 9,527,833 (the #833 patent); 10,457,666 (the #666 patent); and 10,456,399…that was in the #783 patent but was not included in the #284 patent. #284 patent at claims 1, 10, 13…testified that U.S. Patent No. 6,479,500 (the #500 patent) was a blocking patent. Tr. 499:24-500:4. | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
